Amedisys board OK’s $75M stock buyback plan

    The board of directors for Baton Rouge-based home health and hospice firm Amedisys has approved a stock buyback plan, by which the company can opt to repurchase up to $75 million of its outstanding co…


    Already a subscriber? Sign in.

    We are glad you enjoy reading Business Report.

    Continue reading this story and get ACCESS to all our content from any device with a subscription now.

    • Get access to more than a decade of story archives.
    • Get access to our searchable data center of TOP LISTS.
    • Get exclusive content only available to INSIDERS.